Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries.
- DOI
- 10.1080/14737167.2026.2737547
- Published
- 2026-09-21
- Container
- Expert Rev Pharmacoecon Outcomes Res
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14737167.2026.2737547,
title = {Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries.},
author = {Hoxha M and Tashi E and Elezi B and Haxhiu H.},
year = {2026},
journal = {Expert Rev Pharmacoecon Outcomes Res},
doi = {10.1080/14737167.2026.2737547},
url = {https://doi.org/10.1080/14737167.2026.2737547}
}RIS
TY - JOUR TI - Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries. AU - Hoxha M AU - Tashi E AU - Elezi B AU - Haxhiu H. PY - 2026 JO - Expert Rev Pharmacoecon Outcomes Res DO - 10.1080/14737167.2026.2737547 UR - https://doi.org/10.1080/14737167.2026.2737547 ER -
APA
M, H., E, T., B, E., & H., H. (2026). Regulatory and clinical trial exclusion of pregnant women: economic implications for preventive interventions in low-income countries.. Expert Rev Pharmacoecon Outcomes Res. https://doi.org/10.1080/14737167.2026.2737547
Source records
- europe-pmc · retrieved 2026-09-25T05:03:35.742Z